Celgene-Backed China Biotech Startup Is Said to Seek Fresh Funds

(Bloomberg) -- Antengene Corp., a biotechnology startup that counts Celgene Corp. among its backers, is seeking to raise about $100 million in a funding round preceding an initial public offering, ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.